Cargando…
Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein
Vivax malaria is a major cause of morbidity and mortality worldwide, with several million clinical cases per year and 2.5 billion at risk of infection. A vaccine is urgently needed but the most advanced malaria vaccine, VMP001, confers only very low levels of protection against vivax malaria challen...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408485/ https://www.ncbi.nlm.nih.gov/pubmed/32402755 http://dx.doi.org/10.1016/j.vaccine.2020.03.063 |